PYXS Insider Trading

Insider Ownership Percentage: 9.80%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Pyxis Oncology Insider Trading History Chart

This chart shows the insider buying and selling history at Pyxis Oncology by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Pyxis Oncology Share Price & Price History

Current Price: $1.77
Price Change: Price Decrease of -0.12 (-6.35%)
As of 11/26/2024 01:00 AM ET

This chart shows the closing price history over time for PYXS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Pyxis Oncology Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/27/2023Jitendra WadhaneCAOBuy2,500$1.87$4,675.00226,937View SEC Filing Icon  
9/27/2023Pamela Ann ConnealyCFOBuy6,426$1.85$11,888.10810,532View SEC Filing Icon  
9/25/2023Jitendra WadhaneCAOBuy5,000$1.77$8,850.00224,437View SEC Filing Icon  
9/25/2023Pamela Ann ConnealyCFOBuy12,000$1.67$20,040.00804,106View SEC Filing Icon  
9/22/2023Jitendra WadhaneCAOBuy2,500$1.74$4,350.00219,437View SEC Filing Icon  
9/22/2023Pamela Ann ConnealyCFOBuy5,000$1.74$8,700.00792,106View SEC Filing Icon  
9/18/2023Lara SullivanCEOSell8,541$2.10$17,936.102,403,882View SEC Filing Icon  
9/13/2023Lara SullivanCEOSell3,000$2.27$6,810.002,597,265View SEC Filing Icon  
9/11/2023Lara SullivanCEOSell20,000$2.27$45,400.002,605,182View SEC Filing Icon  
3/17/2023Pfizer IncMajor ShareholderBuy1,811,594$2.76$4,999,999.445,952,263View SEC Filing Icon  
4/21/2022Mark ChinDirectorSell1,745,761$3.05$5,324,571.05View SEC Filing Icon  
12/8/2021Darren S. ClineDirectorBuy10,000$9.39$93,900.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Pyxis Oncology (NASDAQ:PYXS)

39.09% of Pyxis Oncology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PYXS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Pyxis Oncology Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024Barclays PLC64,089$0.24M0.0%+275.0%0.108%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC1,084,727$3.98M0.0%+5.5%1.824%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC64,089$0.24M0.0%+275.0%0.108%Search for SEC Filing on Google Icon
11/15/2024Public Employees Retirement System of Ohio29,100$0.11M0.0%N/A0.049%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd84,771$0.31M0.0%+133.6%0.143%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC49,558$0.18M0.0%+40.8%0.083%Search for SEC Filing on Google Icon
11/15/2024State Street Corp951,251$3.49M0.0%+28.0%1.600%Search for SEC Filing on Google Icon
11/15/2024Jacobs Levy Equity Management Inc.382,840$1.41M0.0%N/A0.644%Search for SEC Filing on Google Icon
11/14/2024MetLife Investment Management LLC18,818$69K0.0%+41.1%0.032%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC14,897$55K0.0%N/A0.025%Search for SEC Filing on Google Icon
11/7/2024LMR Partners LLP80,000$0.29M0.0%N/A0.135%Search for SEC Filing on Google Icon
11/6/2024Schulhoff & Co. Inc.122,000$0.45M0.2%+190.5%0.205%Search for SEC Filing on Google Icon
11/6/2024Pier 88 Investment Partners LLC121,610$0.45M0.1%+7.0%0.205%Search for SEC Filing on Google Icon
10/25/2024abrdn plc913,045$3.35M0.0%+28.9%1.537%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC15,800$58K0.0%N/A0.027%Search for SEC Filing on Google Icon
8/15/2024Susquehanna Fundamental Investments LLC57,025$0.19M0.0%-30.8%0.097%Search for SEC Filing on Google Icon
8/15/2024Blue Owl Capital Holdings LP1,046,025$3.46M1.0%N/A1.776%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company19,730$65K0.0%N/A0.034%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC1,336,908$4.43M0.0%+125.3%2.270%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP10,000$33K0.0%-92.5%0.017%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd36,290$0.12M0.0%-44.9%0.062%Search for SEC Filing on Google Icon
8/12/2024Marathon Trading Investment Management LLC16,380$54K0.0%-71.3%0.028%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC96,936$0.32M0.0%-34.5%0.165%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP81,934$0.27M0.0%-19.5%0.139%Search for SEC Filing on Google Icon
8/8/2024Schulhoff & Co. Inc.42,000$0.14M0.1%+90.9%0.071%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.58,252$0.19M0.0%+56.0%0.099%Search for SEC Filing on Google Icon
8/6/2024Pier 88 Investment Partners LLC113,700$0.38M0.1%+121.4%0.193%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers65,287$0.22M0.0%N/A0.111%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp311,630$1.03M0.0%+92.2%0.529%Search for SEC Filing on Google Icon
7/25/2024Fullcircle Wealth LLC12,000$40K0.0%N/A0.020%Search for SEC Filing on Google Icon
5/24/2024Cetera Advisors LLC23,500$100K0.0%N/A0.040%Search for SEC Filing on Google Icon
5/17/2024Ikarian Capital LLC1,662,408$7.08M0.8%N/A2.823%Search for SEC Filing on Google Icon
5/14/2024StemPoint Capital LP1,794,195$7.64M2.0%N/A3.047%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.1,401,425$5.97M0.0%+7.3%2.380%Search for SEC Filing on Google Icon
5/7/2024Susquehanna Fundamental Investments LLC82,447$0.35M0.0%N/A0.140%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC13,809$59K0.0%N/A0.023%Search for SEC Filing on Google Icon
2/20/2024Cable Car Capital LLC61,606$0.11M0.1%N/A0.139%Search for SEC Filing on Google Icon
2/14/2024Vestal Point Capital LP440,000$0.79M0.1%N/A0.993%Search for SEC Filing on Google Icon
2/12/2024Decheng Capital LLC326,810$0.59M0.2%N/A0.737%Search for SEC Filing on Google Icon
1/31/2024abrdn plc708,303$1.28M0.0%N/A1.598%Search for SEC Filing on Google Icon
11/29/2023Decheng Capital Management III Cayman LLC326,810$0.65M0.2%N/A0.737%Search for SEC Filing on Google Icon
11/15/2023Radcliffe Capital Management L.P.53,288$0.11M0.0%N/A0.120%Search for SEC Filing on Google Icon
11/14/2023Schulhoff & Co. Inc.22,000$44K0.0%N/A0.050%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC13,233$26K0.0%N/A0.030%Search for SEC Filing on Google Icon
10/23/2023Commonwealth Equity Services LLC12,950$26K0.0%N/A0.033%Search for SEC Filing on Google Icon
8/14/2023Prelude Capital Management LLC10,352$27K0.0%N/A0.027%Search for SEC Filing on Google Icon
8/11/2023Harvest Investment Services LLC116,428$0.30M0.2%+27.9%0.304%Search for SEC Filing on Google Icon
8/11/2023ExodusPoint Capital Management LP259,561$0.66M0.0%+270.8%0.679%Search for SEC Filing on Google Icon
8/10/2023Cetera Investment Advisers18,260$47K0.0%N/A0.048%Search for SEC Filing on Google Icon
7/10/2023SG Americas Securities LLC20,497$52K0.0%N/A0.054%Search for SEC Filing on Google Icon
5/16/2023Hhlr Advisors LTD.530,692$2.13M0.0%-30.6%1.435%Search for SEC Filing on Google Icon
5/4/2023Barclays PLC118,223$0.47M0.0%-87.5%0.320%Search for SEC Filing on Google Icon
4/27/2023Simplicity Solutions LLC18,110$73K0.0%N/A0.049%Search for SEC Filing on Google Icon
2/15/2023Tang Capital Management LLC3,470,700$4.65M0.7%+145.9%9.888%Search for SEC Filing on Google Icon
2/9/2023Citigroup Inc.357,537$0.48M0.0%+14.5%1.019%Search for SEC Filing on Google Icon
1/12/2023Marquette Asset Management LLC58,862$79K0.0%N/A0.168%Search for SEC Filing on Google Icon
11/15/2022Tang Capital Management LLC1,411,569$2.78M0.3%+2.4%4.022%Search for SEC Filing on Google Icon
11/14/2022RA Capital Management L.P.764,653$1.51M0.0%-19.8%2.179%Search for SEC Filing on Google Icon
8/15/2022Acuta Capital Partners LLC645,149$1.54M0.9%+222.6%1.966%Search for SEC Filing on Google Icon
8/15/2022Laurion Capital Management LP3,170,803$7.55M0.1%+159.9%9.662%Search for SEC Filing on Google Icon
5/16/2022Ghost Tree Capital LLC75,000$0.30M0.1%-74.6%0.228%Search for SEC Filing on Google Icon
5/13/2022Tekla Capital Management LLC708,303$2.63M0.1%+424.7%2.157%Search for SEC Filing on Google Icon
2/16/2022Ghost Tree Capital LLC295,000$3.24M1.2%N/A0.900%Search for SEC Filing on Google Icon
2/15/2022Laurion Capital Management LP1,162,332$12.75M0.1%N/A3.548%Search for SEC Filing on Google Icon
2/15/2022Davidson Kempner Capital Management LP10,000$0.11M0.0%N/A0.031%Search for SEC Filing on Google Icon
2/14/2022Citadel Advisors LLC1,521,617$16.48M0.0%N/A4.644%Search for SEC Filing on Google Icon
2/14/2022Deerfield Management Company L.P. Series C311,754$3.42M0.1%N/A0.952%Search for SEC Filing on Google Icon
2/14/2022Hhlr Advisors LTD.764,406$8.39M0.1%N/A2.333%Search for SEC Filing on Google Icon
2/14/2022Perceptive Advisors LLC1,944,114$21.33M0.3%N/A5.934%Search for SEC Filing on Google Icon
2/14/2022Sandia Investment Management LP10,000$0.11M0.0%N/A0.031%Search for SEC Filing on Google Icon
2/14/2022Ghisallo Capital Management LLC30,000$0.33M0.0%N/A0.092%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp89,235$0.98M0.0%N/A0.272%Search for SEC Filing on Google Icon
2/2/2022New York State Common Retirement Fund6,277$69K0.0%N/A0.019%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Pyxis Oncology logo
Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat cancers. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an investigational novel ADC consisting of human immunoglobulin G1 (IgG1), which is in Phase 1 clinical trial to treat patients with relapsed or refractory solid tumors; and lead immuno-oncology (IO) product candidate is PYX-106, an investigational fully human IgG1 Siglec-15-targeting antibody that is in Phase 1 clinical trial to treat patients with advanced solid tumors. The company is also developing PYX-107, a CD40 agonist with demonstrated anti-cancer activity in patients who previously progressed on PD-(L)1 inhibitors, which is in Phase 2 clinical trial for the treatment of solid tumors, such as soft tissue sarcomas, esophageal and gastroesophageal junction, cancers, and melanoma in combination with chemotherapy, radiation therapy, and immunotherapy. It has in-license agreement with Pfizer Inc. to develop and commercialize ADC product candidates directed to certain licensed targets, including PYX-201 and PYX-203, and products containing the ADC product candidates; and Biosion USA, Inc. for development, manufacture, and commercialization of PYX-106, an IO product candidate. Pyxis Oncology, Inc. was incorporated in 2018 and is headquartered in Boston, Massachusetts.
Read More on Pyxis Oncology

Today's Range

Now: $1.77
Low: $1.77
High: $1.89

50 Day Range

MA: $3.57
Low: $1.77
High: $4.74

52 Week Range

Now: $1.77
Low: $1.48
High: $6.85

Volume

2,328,229 shs

Average Volume

748,110 shs

Market Capitalization

$105.26 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.27

Who are the company insiders with the largest holdings of Pyxis Oncology?

Pyxis Oncology's top insider investors include:
  1. Pfizer Inc (Major Shareholder)
  2. Lara Sullivan (CEO)
  3. Pamela Ann Connealy (CFO)
  4. Jitendra Wadhane (CAO)
Learn More about top insider investors at Pyxis Oncology.

Who are the major institutional investors of Pyxis Oncology?

Pyxis Oncology's top institutional shareholders include:
  1. Geode Capital Management LLC — 1.82%
  2. State Street Corp — 1.60%
  3. abrdn plc — 1.54%
  4. Jacobs Levy Equity Management Inc. — 0.64%
  5. Schulhoff & Co. Inc. — 0.21%
  6. Pier 88 Investment Partners LLC — 0.20%
Learn More about top institutional investors of Pyxis Oncology stock.

Which institutional investors are buying Pyxis Oncology stock?

In the last quarter, PYXS stock was bought by institutional investors including:
  1. Jacobs Levy Equity Management Inc.
  2. State Street Corp
  3. abrdn plc
  4. LMR Partners LLP
  5. Schulhoff & Co. Inc.
  6. Geode Capital Management LLC
  7. XTX Topco Ltd
  8. Barclays PLC
During the previous year, these company insiders have bought Pyxis Oncology stock:
  1. Pfizer Inc (Major Shareholder)
  2. Lara Sullivan (CEO)
  3. Pamela Ann Connealy (CFO)
Learn More investors buying Pyxis Oncology stock.